Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1999-01-05
2000-08-01
Carr, Deborah D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514552, 514613, 514623, 514627, 514628, A01N 3706
Patent
active
060967846
ABSTRACT:
Inhibitors of oleamide hydrolase, responsible for the hydrolysis of an endogenous sleep-inducing lipid (1, cis-9-octadecenamide) were designed and synthesized. The most potent inhibitors possess an electrophilic carbonyl group capable of reversibly forming a (thio) hemiacetal or (thio) hemiketal to mimic the transition state of a serine or cysteine protease catalyzed reaction. In particular, the tight binding .alpha.-keto ethyl ester 8 (1.4 nM) and the trifluoromethyl ketone inhibitor 12 (1.2 nM) were found to have exceptional inhibitory activity. In addition to the inhibitory activity, some of the inhibitors displayed agonist activity which resulted in the induction of sleep in laboratory animals.
REFERENCES:
Chem abstr of Koutek et al, Journal of Biological Chemistry, vol. 269, No. 37, pp. 22937-22940, 121:221790, 1994.
Chem. abstr. of JP-01086884, 111:193095, 1989.
Boger Dale L.
Henriksen Steven J.
Lerner Richard A.
Wong Chi-Huey
Carr Deborah D.
Lewis Donald G.
The Scripps Research Institute
LandOfFree
Inhibitors of oleamide hydrolase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of oleamide hydrolase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of oleamide hydrolase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664530